Atlas Trials

Evaluation of ADG20 for the Prevention of COVID-19

Clinical trial NCT04859517 · TERMINATED

Trial details

NCT number
NCT04859517
Sponsor
Invivyd, Inc.
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2021-04-27
Primary completion
2022-11-04
Enrollment
2582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.